Research 1st
Severe ME, POTS & MCAS.
- Messages
- 768
This looks an interesting idea, mainly because of viruses in insects which looks like a totally novel idea in ME and CFS.
Questions:
1) Are Simmaron really not testing a very common CFS pathogen found by Lyme physicians (Chlamydia Pneumoniae)? and the not uncommon Mycoplasma Pneumoniae or Bartonella Henselea/Quintana) too? Maybe this was just missed in the blog?
2) Are all known pathogenic strains of Borrelia being tested? (CDC B31 Burgodferi strain is the original disease). What about Borrelia Garinii, Borrelia Bavariensis, Borrelia Miyamotoi, Borrelia Lonestari, Borrelia Afzelli?
Before we get excited lets run over the basics that hobble us so much in actively over-turning our demise:
1) Is this a genuine probable ME cohort study (neurological signs and damage such as autoimmunity/POTS?) or a Fukuda CFS study or Canadian CFS study?
2) If so, what % of the 'CFS' blood samples meet each criteria? Fukuda is not a disease, so you'd need at minimum all patients meet Canadian CFS criteria when looking at people for consequence of chronic infections - not simple fatigue.
3) If so, were the 'CFS' patients vetted before the blood was drawn by a doctor who are claimed to meet this criteria?
4) If not using fresh samples, how old is the blood (if frozen) and how is it stored and in what tubes? Does freezing or other storage conditions affect accuracy of the tests? You may remember a group 'accidentally' did this in the past with Mycoplasma - thus there was no link to 'CFS', as the Mycoplasma would be destroyed in the tube. NB: This can easily happen again if people don't think before using the wrong type of collection tube preservative for the blood.
The above are important points to consider for a studies possible legitimacy when published, and possible claimed relevance to ME or CFS even if negative. So far Dr Lipkin has failed to find any pathogens in 'CFS', despite people on this forum testing positive for the infections Dr Lipkin cannot find (in people without ME) and endless CFS studies also finding these pathogens - thus his 'CFS' samples are not people with immune suppression = no infection and not Organic CFS or ME. In contrast Dr Montoya finds infections and finds high levels of cytokines in more severe patients - the opposite finding of Dr Lipkin and the psychiatrist he's done 40 papers with before.
This is why criteria are so important in pathogen studies, sample storage and handling, and having patients with a 'clinical diagnosis' well vetted by an ME expert to be called an 'ME patient' when it comes to validity of scientific papers using the word Myalgic Encephalomyelitis in their title.
Questions:
1) Are Simmaron really not testing a very common CFS pathogen found by Lyme physicians (Chlamydia Pneumoniae)? and the not uncommon Mycoplasma Pneumoniae or Bartonella Henselea/Quintana) too? Maybe this was just missed in the blog?
2) Are all known pathogenic strains of Borrelia being tested? (CDC B31 Burgodferi strain is the original disease). What about Borrelia Garinii, Borrelia Bavariensis, Borrelia Miyamotoi, Borrelia Lonestari, Borrelia Afzelli?
Before we get excited lets run over the basics that hobble us so much in actively over-turning our demise:
1) Is this a genuine probable ME cohort study (neurological signs and damage such as autoimmunity/POTS?) or a Fukuda CFS study or Canadian CFS study?
2) If so, what % of the 'CFS' blood samples meet each criteria? Fukuda is not a disease, so you'd need at minimum all patients meet Canadian CFS criteria when looking at people for consequence of chronic infections - not simple fatigue.
3) If so, were the 'CFS' patients vetted before the blood was drawn by a doctor who are claimed to meet this criteria?
4) If not using fresh samples, how old is the blood (if frozen) and how is it stored and in what tubes? Does freezing or other storage conditions affect accuracy of the tests? You may remember a group 'accidentally' did this in the past with Mycoplasma - thus there was no link to 'CFS', as the Mycoplasma would be destroyed in the tube. NB: This can easily happen again if people don't think before using the wrong type of collection tube preservative for the blood.
The above are important points to consider for a studies possible legitimacy when published, and possible claimed relevance to ME or CFS even if negative. So far Dr Lipkin has failed to find any pathogens in 'CFS', despite people on this forum testing positive for the infections Dr Lipkin cannot find (in people without ME) and endless CFS studies also finding these pathogens - thus his 'CFS' samples are not people with immune suppression = no infection and not Organic CFS or ME. In contrast Dr Montoya finds infections and finds high levels of cytokines in more severe patients - the opposite finding of Dr Lipkin and the psychiatrist he's done 40 papers with before.
This is why criteria are so important in pathogen studies, sample storage and handling, and having patients with a 'clinical diagnosis' well vetted by an ME expert to be called an 'ME patient' when it comes to validity of scientific papers using the word Myalgic Encephalomyelitis in their title.
Last edited: